Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-04-29 @ 11:20 PM
Study NCT ID:
NCT00677820
Status:
COMPLETED
Last Update Posted:
2010-10-22
First Post:
2008-05-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine
Sponsor:
MedImmune LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MI-MA182
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Raburn Mallory M.D.\Senior Director, Clinical Development
Old Organization:
MedImmune LLC, an affiliate of AstraZeneca AB